Tyra Biosciences, Inc. (TYRA) Form 10-Q Quarterly Reports
Tyra Biosciences, Inc. (TYRA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TYRA
CIK: 1863127
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerTim Holl
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-09-21 | — | SCHEDULE 13G Filing | 0000921895-26-002613 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 | 0001193125-26-394738 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 | 0001193125-26-394734 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 | 0001193125-26-394731 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-17 | — | SCHEDULE 13D/A Filing | 0001346824-26-000237 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 Filing | 0001231919-26-001194 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-17 | — | SCHEDULE 13G Filing | 0001104659-26-108569 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-14 | 8-K | 0001193125-26-390951 | View SEC Doc Filr Page |
| 424B5 | 2026-09-15 | — | 424B5 | 0001193125-26-390947 | View SEC Doc Filr Page |
| FWP | 2026-09-14 | — | FWP | 0001193125-26-389801 | View SEC Doc Filr Page |
| S-3ASR | 2026-09-14 | — | S-3ASR | 0001193125-26-389752 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-09 | 4 | 0001193125-26-389333 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | 8-K | 0001193125-26-385886 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001804218-26-000003 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000908834-26-000427 | View SEC Doc Filr Page |
| 424B5 | 2026-08-04 | — | 424B5 | 0001193125-26-333055 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001193125-26-332995 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001193125-26-332752 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-30 | — | SCHEDULE 13G Filing | 0002012383-26-003114 | View SEC Doc Filr Page |
| 144 | 2026-06-26 | — | 144 Filing | 0001628280-26-045813 | View SEC Doc Filr Page |
| 8-K | 2026-06-02 | 2026-05-28 | 8-K | 0001193125-26-253435 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-05-28 | 4 Filing | 0001231919-26-000590 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-05-28 | 4 | 0001193125-26-251539 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-05-28 | 4 | 0001193125-26-251538 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-05-28 | 4 | 0001193125-26-251537 | View SEC Doc Filr Page |